Reversal of Platelet Inhibition in Patients Receiving Ticagrelor

Antiplatelet treatment is one of the pillars of contemporary therapy in acute coronary syndromes. It is based on dual antiplatelet therapy (DAPT) consisting of aspirin and a P2Y12 receptor inhibitor. Antiaggregatory treatment reduces ischemic events, but at cost of increased bleeding rates. As a res...

Full description

Bibliographic Details
Main Authors: Piotr Adamski, Grzegorz Skonieczny, Tomasz Hajdukiewicz, Adam Kern, Jacek Kubica
Format: Article
Language:English
Published: IMR Press 2022-09-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/23/9/10.31083/j.rcm2309300